{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T14:12:40Z","timestamp":1784988760832,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ekir.2018.08.011","type":"journal-article","created":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T16:47:23Z","timestamp":1535820443000},"page":"48-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Clinical Manifestations and Long-term Outcomes of IgG4-Related Kidney and\u00a0Retroperitoneal Involvement in\u00a0a\u00a0United Kingdom IgG4-Related Disease Cohort"],"prefix":"10.1016","volume":"4","author":[{"given":"Rhys D.R.","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamsin","family":"Cargill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Goodchild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Rodriguez-Justo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Pepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L.","family":"Culver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9976","key":"10.1016\/j.ekir.2018.08.011_bib1","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","article-title":"IgG4-related disease","volume":"385","author":"Kamisawa","year":"2015","journal-title":"Lancet Lond Engl"},{"issue":"6","key":"10.1016\/j.ekir.2018.08.011_bib2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-Related Disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ekir.2018.08.011_bib3","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/art.34593","article-title":"Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations","volume":"64","author":"Stone","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.ekir.2018.08.011_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrneph.2015.95","article-title":"IgG4-related disease and the kidney","volume":"11","author":"Cortazar","year":"2015","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.ekir.2018.08.011_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ki.2013.393","article-title":"IgG4-related kidney disease","volume":"85","author":"Saeki","year":"2014","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.ekir.2018.08.011_bib6","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1681\/ASN.2011010062","article-title":"Diagnosis of IgG4-related tubulointerstitial nephritis","volume":"22","author":"Raissian","year":"2011","journal-title":"J Am Soc Nephrol JASN"},{"issue":"5","key":"10.1016\/j.ekir.2018.08.011_bib7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10157-011-0521-2","article-title":"Proposal for diagnostic criteria for IgG4-related kidney disease","volume":"15","author":"Kawano","year":"2011","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"10.1016\/j.ekir.2018.08.011_bib8","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ki.2013.191","article-title":"The clinical course of patients with IgG4-related kidney disease","volume":"84","author":"Saeki","year":"2013","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.ekir.2018.08.011_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MD.0b013e318289610f","article-title":"Rethinking Ormond\u2019s disease: \u201cidiopathic\u201d retroperitoneal fibrosis in the era of IgG4-related disease","volume":"92","author":"Khosroshahi","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ekir.2018.08.011_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/609795","article-title":"Immunohistochemical Characteristics of IgG4-Related Tubulointerstitial Nephritis: Detailed Analysis of 20 Japanese Cases","volume":"2012","author":"Kawano","year":"2012","journal-title":"Int J Rheumatol"},{"issue":"10","key":"10.1016\/j.ekir.2018.08.011_bib11","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ki.2010.271","article-title":"Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis","volume":"78","author":"Saeki","year":"2010","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.ekir.2018.08.011_bib12","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.18632\/oncotarget.23103","article-title":"Clinical features and prognostic factors of ten patients with renal failure caused by IgG4-related retroperitoneal fibrosis","volume":"9","author":"Zhang","year":"2018","journal-title":"Oncotarget"},{"issue":"14","key":"10.1016\/j.ekir.2018.08.011_bib13","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2169\/internalmedicine.52.0306","article-title":"Clinical features of 10 patients with IgG4-related retroperitoneal fibrosis","volume":"52","author":"Chiba","year":"2013","journal-title":"Intern Med Tokyo Jpn"},{"issue":"12","key":"10.1016\/j.ekir.2018.08.011_bib14","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/PAS.0b013e3181b72882","article-title":"Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4","volume":"33","author":"Zen","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ekir.2018.08.011_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.rmed.2017.10.005","article-title":"Thoracic involvement in IgG4-related disease in a UK-based patient cohort","volume":"132","author":"Corcoran","year":"2017","journal-title":"Respir Med"},{"issue":"10","key":"10.1016\/j.ekir.2018.08.011_bib16","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/ajg.2014.223","article-title":"Type 1 Autoimmune Pancreatitis and IgG4-Related Sclerosing Cholangitis Is Associated With Extrapancreatic Organ Failure, Malignancy, and Mortality in a Prospective UK Cohort","volume":"109","author":"Huggett","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ekir.2018.08.011_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1741-7015-4-23","article-title":"Hyper-IgG4 disease: report and characterisation of a new disease","volume":"4","author":"Neild","year":"2006","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.ekir.2018.08.011_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"issue":"9","key":"10.1016\/j.ekir.2018.08.011_bib19","first-page":"1181","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"Suppl 18","key":"10.1016\/j.ekir.2018.08.011_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00535-007-2046-8","article-title":"Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic\u2019s HISORt criteria","volume":"42","author":"Chari","year":"2007","journal-title":"J Gastroenterol"},{"issue":"15","key":"10.1016\/j.ekir.2018.08.011_bib21","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.1097\/MD.0000000000000680","article-title":"IgG4-related disease: dataset of 235 consecutive patients","volume":"94","author":"Inoue","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"13","key":"10.1016\/j.ekir.2018.08.011_bib22","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.4103\/0366-6999.184459","article-title":"Types of Organ Involvement in Patients with Immunoglobulin G4-related Disease","volume":"129","author":"Chen","year":"2016","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"10.1016\/j.ekir.2018.08.011_bib23","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/kev203","article-title":"Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients","volume":"54","author":"Lin","year":"2015","journal-title":"Rheumatol Oxf Engl"},{"issue":"9","key":"10.1016\/j.ekir.2018.08.011_bib24","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/art.39205","article-title":"IgG4-Related Disease: Baseline clinical and laboratory features in 125 patients with biopsy-proven disease","volume":"67","author":"Wallace","year":"2015","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"32","key":"10.1016\/j.ekir.2018.08.011_bib25","doi-asserted-by":"crossref","first-page":"e1275","DOI":"10.1097\/MD.0000000000001275","article-title":"IgG4-Related Disease: Results From a Multicenter Spanish Registry","volume":"94","author":"Fern\u00e1ndez-Codina","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.ekir.2018.08.011_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/03009742.2015.1055796","article-title":"IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients","volume":"45","author":"Campochiaro","year":"2016","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.ekir.2018.08.011_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MD.0b013e3182433d77","article-title":"Igg4-related Systemic Disease: Features and Treatment Response in a French Cohort","volume":"91","author":"Ebbo","year":"2012","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.ekir.2018.08.011_bib28","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1097\/PAS.0b013e3181f7266b","article-title":"IgG4-related disease: a cross-sectional study of 114 cases","volume":"34","author":"Zen","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.ekir.2018.08.011_bib29","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/art.39686","article-title":"IgG4-Related Disease: Retrospective Analysis of One Hundred Sixty-Six Patients","volume":"68","author":"Sekiguchi","year":"2016","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"1","key":"10.1016\/j.ekir.2018.08.011_bib30","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13075-017-1467-x","article-title":"New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases","volume":"19","author":"Yamada","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.ekir.2018.08.011_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12891-015-0858-x","article-title":"Tubulointerstitial nephritis in primary Sj\u00f6gren syndrome: clinical manifestations and response to treatment","volume":"17","author":"Evans","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.ekir.2018.08.011_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kev223","article-title":"Renal involvement in primary Sj\u00f6gren\u2019s syndrome","author":"Evans","year":"2015","journal-title":"Rheumatol Oxf Engl"},{"issue":"1","key":"10.1016\/j.ekir.2018.08.011_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaci.2013.07.044","article-title":"Phenotypic differences between IgG4+ and IgG1+ B cells point to distinct regulation of the IgG4 response","volume":"133","author":"Lighaam","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.ekir.2018.08.011_bib34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ki.2012.382","article-title":"Membranous glomerulonephritis is a manifestation of IgG4-related disease","volume":"83","author":"Alexander","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2018.08.011_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/139409","article-title":"IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 Receptor","volume":"2012","author":"Khosroshahi","year":"2012","journal-title":"Int J Rheumatol"},{"issue":"5","key":"10.1016\/j.ekir.2018.08.011_bib36","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ebiom.2015.03.003","article-title":"Mitochondrial-dependent Autoimmunity in Membranous Nephropathy of IgG4-related Disease","volume":"2","author":"Buelli","year":"2015","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.ekir.2018.08.011_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/2040622313485275","article-title":"Prevention of infection caused by immunosuppressive drugs in gastroenterology","volume":"4","author":"Orlicka","year":"2013","journal-title":"Ther Adv Chronic Dis"},{"issue":"30","key":"10.1016\/j.ekir.2018.08.011_bib38","doi-asserted-by":"crossref","first-page":"21337","DOI":"10.18632\/oncotarget.25095","article-title":"IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapy","volume":"9","author":"Quattrocchio","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ekir.2018.08.011_bib39","unstructured":"IgG4-RD Registry Study - IgG4-RD. http:\/\/igg4-rd.ndm.ox.ac.uk\/igg4-rd-registry-study. Accessed May 27, 2018."},{"key":"10.1016\/j.ekir.2018.08.011_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.14758","article-title":"Recurrent IgG4-related tubulointerstitial nephritis concurrent with chronic active antibody mediated rejection: A Case Report","author":"Chibbar","year":"2018","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024918301967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024918301967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T10:15:57Z","timestamp":1717409757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024918301967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S2468024918301967"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2018.08.011","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Manifestations and Long-term Outcomes of IgG4-Related Kidney and\u00a0Retroperitoneal Involvement in\u00a0a\u00a0United Kingdom IgG4-Related Disease Cohort","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2018.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}